VKTX is trading at $34.42 (6.33%) up today following fresh takeover chatter and continued analyst optimism.
- CNBC recently flagged Viking Therapeutics as a potential acquisition target, sparking a sharp pre-market and intraday rebound.
- The stock's strength appears company-specific as it outperforms a weaker broader market, building on a 6.55% gain from the prior session.